Fresenius Medical Care

In 2024, Fresenius Medical Care reported total carbon emissions of approximately 3,680,827,000 kg CO2e. This figure includes 360,803,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 326,636,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, heat, and steam. The majority of their emissions, about 2,993,388,000 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions in the value chain. Fresenius Medical Care has set ambitious climate commitments, aiming to reduce both Scope 1 and Scope 2 emissions by 50% by 2030, compared to 2020 levels. This target reflects their commitment to sustainability and aligns with industry standards for greenhouse gas reduction. Additionally, the company has committed to achieving net-zero emissions across all scopes by 2050, demonstrating a long-term dedication to addressing climate change. In previous years, their emissions were as follows: in 2023, they reported 387,049,000 kg CO2e for Scope 1 and 405,340,000 kg CO2e for Scope 2; in 2022, Scope 1 emissions were 258,400,000 kg CO2e and Scope 2 emissions were 401,100,000 kg CO2e. These figures indicate a growing awareness and response to their environmental impact. Fresenius Medical Care's proactive approach to reducing carbon emissions and their clear targets position them as a responsible leader in the healthcare sector, committed to mitigating climate change and promoting sustainability.